Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 7
1986 2
1987 1
1988 4
1990 1
1991 1
1992 1
1993 5
1994 3
1995 1
1996 2
1997 3
1998 7
1999 8
2000 14
2001 12
2002 13
2003 10
2004 8
2005 11
2006 7
2007 5
2008 7
2009 8
2010 14
2011 13
2012 19
2013 7
2014 6
2015 11
2016 7
2017 8
2018 8
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Results by year
Filters applied: . Clear all
Page 1
Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases.
Correia S, Bridges R, Wegner F, Venturini C, Palser A, Middeldorp JM, Cohen JI, Lorenzetti MA, Bassano I, White RE, Kellam P, Breuer J, Farrell PJ. Correia S, et al. J Virol. 2018 Oct 29;92(22):e01132-18. doi: 10.1128/JVI.01132-18. Print 2018 Nov 15. J Virol. 2018. PMID: 30111570 Free PMC article.
EBV from saliva of U.S. patients with chronic active EBV infection aligned with the wild-type EBV genome with no evidence of WZhet rearrangements. ...It contributes to several types of cancer, including Hodgkin's lymphoma, Burkitt's lymphoma, diffuse large B …
EBV from saliva of U.S. patients with chronic active EBV infection aligned with the wild-type EBV genome with no evidence of WZhet re …
Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization.
Liu Z, Yu KJ, Coghill AE, Brenner N, Cao SM, Chen CJ, Chen Y, Doolan DL, Hsu WL, Labo N, Middeldorp JM, Miley W, Simon J, Wang CP, Waterboer T, Whitby D, Xie SH, Ye W, Hildesheim A. Liu Z, et al. J Clin Microbiol. 2019 Oct 23;57(11):e01107-19. doi: 10.1128/JCM.01107-19. Print 2019 Nov. J Clin Microbiol. 2019. PMID: 31434722 Free PMC article.
IgA antibodies targeting Epstein-Barr virus (EBV) have been proposed for screening for nasopharyngeal carcinoma (NPC). However, methods differ, and the antigens used in these assays differ considerably between laboratories. ...
IgA antibodies targeting Epstein-Barr virus (EBV) have been proposed for screening for nasopharyngeal carcinoma (NPC). However, metho …
Reactivation of Epstein-Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn(2+)-chelating function.
Jiang L, Lung HL, Huang T, Lan R, Zha S, Chan LS, Thor W, Tsoi TH, Chau HF, Boreström C, Cobb SL, Tsao SW, Bian ZX, Law GL, Wong WT, Tai WC, Chau WY, Du Y, Tang LHX, Chiang AKS, Middeldorp JM, Lo KW, Mak NK, Long NJ, Wong KL. Jiang L, et al. Proc Natl Acad Sci U S A. 2019 Dec 10;116(52):26614-24. doi: 10.1073/pnas.1915372116. Online ahead of print. Proc Natl Acad Sci U S A. 2019. PMID: 31822610 Free PMC article.
Epstein-Barr nuclear antigen 1 (EBNA1) plays a vital role in the maintenance of the viral genome and is the only viral protein expressed in nearly all forms of Epstein-Barr virus (EBV) latency and EBV-associated diseases, including numerous cancer types. ...
Epstein-Barr nuclear antigen 1 (EBNA1) plays a vital role in the maintenance of the viral genome and is the only viral protein expressed in …
Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.
Correia S, Palser A, Elgueta Karstegl C, Middeldorp JM, Ramayanti O, Cohen JI, Hildesheim A, Fellner MD, Wiels J, White RE, Kellam P, Farrell PJ. Correia S, et al. J Virol. 2017 Jul 12;91(15):e00375-17. doi: 10.1128/JVI.00375-17. Print 2017 Aug 1. J Virol. 2017. PMID: 28515295 Free PMC article.
Viral gene sequences from an enlarged set of about 200 Epstein-Barr virus (EBV) strains, including many primary isolates, have been used to investigate variation in key viral genetic regions, particularly LMP1, Zp, gp350, EBNA1, and the BART microRNA (miRNA) cluster 2. ...
Viral gene sequences from an enlarged set of about 200 Epstein-Barr virus (EBV) strains, including many primary isolates, have been u …
Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
McHugh D, Caduff N, Barros MHM, Rämer PC, Raykova A, Murer A, Landtwing V, Quast I, Styles CT, Spohn M, Fowotade A, Delecluse HJ, Papoudou-Bai A, Lee YM, Kim JM, Middeldorp J, Schulz TF, Cesarman E, Zbinden A, Capaul R, White RE, Allday MJ, Niedobitek G, Blackbourn DJ, Grundhoff A, Münz C. McHugh D, et al. Cell Host Microbe. 2017 Jul 12;22(1):61-73.e7. doi: 10.1016/j.chom.2017.06.009. Cell Host Microbe. 2017. PMID: 28704654 Free article.
The human tumor viruses Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) establish persistent infections in B cells. ...
The human tumor viruses Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) establish persistent infecti …
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.
Lin W, Yip YL, Jia L, Deng W, Zheng H, Dai W, Ko JMY, Lo KW, Chung GTY, Yip KY, Lee SD, Kwan JS, Zhang J, Liu T, Chan JY, Kwong DL, Lee VH, Nicholls JM, Busson P, Liu X, Chiang AKS, Hui KF, Kwok H, Cheung ST, Cheung YC, Chan CK, Li B, Cheung AL, Hau PM, Zhou Y, Tsang CM, Middeldorp J, Chen H, Lung ML, Tsao SW. Lin W, et al. Nat Commun. 2018 Nov 7;9(1):4663. doi: 10.1038/s41467-018-06889-5. Nat Commun. 2018. PMID: 30405107 Free PMC article.
Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease.
Middeldorp JM. Middeldorp JM. Curr Top Microbiol Immunol. 2015;391:289-323. doi: 10.1007/978-3-319-22834-1_10. Curr Top Microbiol Immunol. 2015. PMID: 26428379 Review.
Epstein-Barr virus (EBV) is widely distributed in the world and associated with a still increasing number of acute, chronic, malignant and autoimmune disease syndromes. ...
Epstein-Barr virus (EBV) is widely distributed in the world and associated with a still increasing number of acute, chronic, malignan …
Functional delivery of viral miRNAs via exosomes.
Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Würdinger T, Middeldorp JM. Pegtel DM, et al. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33. doi: 10.1073/pnas.0914843107. Epub 2010 Mar 18. Proc Natl Acad Sci U S A. 2010. PMID: 20304794 Free PMC article.
Virus and cell RNAs expressed during Epstein-Barr virus replication.
Yuan J, Cahir-McFarland E, Zhao B, Kieff E. Yuan J, et al. J Virol. 2006 Mar;80(5):2548-65. doi: 10.1128/JVI.80.5.2548-2565.2006. J Virol. 2006. PMID: 16474161 Free PMC article.
Changes in Epstein-Barr virus (EBV) and cell RNA levels were assayed following immunoglobulin G (IgG) cross-linking-induced replication in latency 1-infected Akata Burkitt B lymphoblasts. ...Middeldorp, and N. Raab-Traub, J. Virol. 74:7610-7618, 2000). EBV replicati …
Changes in Epstein-Barr virus (EBV) and cell RNA levels were assayed following immunoglobulin G (IgG) cross-linking-induced replicati …
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.
Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Coghill AE, et al. Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301829 Free PMC article.
Background Epstein-Barr virus (EBV) is necessary for the development of nasopharyngeal carcinoma (NPC). By adulthood, approximately 90% of individuals test EBV-positive, but only a fraction develop cancer. Factors that identify which individuals are most likely to develop …
Background Epstein-Barr virus (EBV) is necessary for the development of nasopharyngeal carcinoma (NPC). By adulthood, approximately 9 …
222 results
Jump to page
Feedback